1. Familial breast cancer. The classification and care of women at risk of familial breast cancer in primary, secondary and tertiary care – CG41;National Institute for Health and Clinical Excellence,2006
2. Gefitinib for the first-line treatment of locally advanced or metastatic non-small-cell lung cancer. TA192;National Institute for Health and Clinical Excellence,2010
3. Academy of Medical Sciences. (2007) Optimising stratified medicines R&D: addressing scientific and economic issues. Report of a meeting organised by AMS, Roche and GE Healthcare
4. The microeconomics of personalized medicine: today's challenge and tomorrow's promise;Davis;Nat. Rev. Drug Discov.,2009
5. Enabling Personalized Medicine through Health Information Technology;West,2011